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Abstract
Background: Locally advanced colorectal cancers are best treated with multivisceral resections. The aim of this
study is to evaluate early and late results after multivisceral resections.
Methods: All patients operated for primary colorectal cancer between 2001 and 2010 were -reviewed. These were
compared within the patients underwent single organ and multivisceral resections: demographics, tumor and
procedure related parameters, perioperative results, early oncological outcomes and 5-year survival.
Results: A total of 354 patients (59.6 ± 13.8 years old, 210 [59.3%] males) were abstracted. Ninety (25.4%) patients
underwent multivisceral resections for clinical T4 tumors and en-bloc R0 resection was achieved in 82 (91.1%). Only
31 (34.4% and 8.8% of clinical T4 and all cancers, respectively) cases had actual adjacent organ invasions (pT4).
Males (20%) had lower risk for locally advanced tumors than females (33.3%) (p < 0.05). PT4 cancers were more
common, if the clinical T4 tumor is located in the colon (48.8% vs 21.3%; p < 0.01). Laparoscopy was seldom
initiated and the risk of conversion was higher in clinical T4 tumors (p < 0.05). The rates of sphincter-saving
procedures were not different. Operation time, bleeding and transfusion requirements increased when multivisceral
resections were necessitated (p < 0.05), but hospital stay, complications and 30-day mortality rates were similar.
The 5-year survival rates were identical (p > 0.05).
Conclusions: Clinical T4 tumors are not rare and more common in women. An actual invasion (pT4) may be
observed in one third of all clinical T4 tumors, and more frequent in colon cancers. An en-bloc, R0, multivisceral
resection may be achieved in most cases. Multivisceral resections do not alter the rates of sphincter-saving
procedures, morbidity and 30-day mortality; do not worsen survival but increase operation time, intraoperative
bleeding and perioperative transfusion requirements.
Keywords: Colorectal cancer, multivisceral resection, locally advanced colorectal cancer, pT4 tumor, morbidity and
mortality, survival
Background
Colorectal cancer is a common problem in western
countries regarding incidence and death rates [1]. It is
also estimated to be increasing in developing countries.
A recent analysis by Ministry of Health has shown that
the age standardized rates for colorectal cancer are 12.1
and 8.0 for men and women, making it the third and
the second most common tumor in men and women,
respectively, in Turkey [2]. If the cancer has grown
through the wall of the colon or rectum and into other
adjacent tissues or organs, it is named as a T4 or a
locally advanced tumor which is detected during 5 to
22% of all surgical interventions performed for the man-
agement of colorectal cancer [3,4].
Surgery remains the principal treatment technique in
most of the patients with colorectal cancer, even for the
most of those with a locally advanced tumor. The deci-
sion-making for a surgeon confronting a T4 colorectal
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between the cancer and the adjacent tissue have an
unacceptably high risk of being malignant and the
intraoperative assessment of nature of adhesions are
often inaccurate [5]. Accordingly, guidelines have
recommended en-bloc multivisceral resections for treat-
ment of these tumors, since most studies have shown
that this procedure improves the possibility of R0 mar-
gins associated with a better local control and improved
overall survival [6-8]. However, surgery related mortality
rates after multivisceral resections have been reported to
be up to 12% [9-11]. Since limited number of studies
included comparative data and the results are conflict-
ing, it remains unclear wheth e ro rn o tm u l t i v i s c e r a l
resections are making worse the early postoperative
non-oncological results compared to standard single
organ removals. Thus, this study aims to evaluate the
results after multivisceral resections performed for the
treatment of locally advanced colorectal cancers, and
compare the outcomes with those obtained from stan-
dard resections.
Methods
Institutional review board of Kartal Education and
Research Hospital approved the design and content of
the study prior to data abstraction (Reference number:
B104ISM4340029/1009/3). A chart review was initiated
for all patients operated for colorectal cancer between
January 2001 and July 2010 in our institution. In addi-
tion, missed or confirmative information was obtained
from computer-based records that have been used to
collect prospective data in our unit since 2006. In order
to standardize the information, data about emergency
procedures were excluded. Furthermore, patients under-
going operation for a benign or recurrent disease, those
presenting with only dysplasia or in situ cancers or
those with cancers other than adenocarcinomas were
excluded from the study and further analyses. The study
patients were routinely discussed in a multidisciplinary
council prior to initiation of the treatment, if the preo-
perative evaluation tools showed a possible risk in
achieving R0 resection, and the indication for surgery
particularly in patients with a rectal cancer was decided
only if an R0 resection was predicted. Advanced staged
(T3-4 or node positive) tumors located at two thirds of
the rectum received neoadjuvant chemoradiation ther-
apy. Patients were routinely received a total colono-
scopy, unless an obstruction was not the case. In
addition to the abdominal ultrasonography, which was
used in all cases as the initial diagnostic tool particularly
for discovering hepatic metastasis; colon and rectal can-
cer patients were evaluated with computed tomography
(CT) and magnetic resonance imaging, respectively.
Thorax was examined with either a plain graph or a CT
which was the case in recent years. Patients with sus-
pected clinical T4 tumors received further diagnostic
tools including CT-angiograph, or other conventional
imaging tools with barium meal when indicated by the
council. All procedures were performed or supervised
by a single surgeon (MO). During the initial stage of the
study period, the operations were performed via a lapar-
otomy; however since 2006, laparoscopy and hand-
assisted laparoscopy have gradually become the pre-
ferred techniques for all colorectal tumors. Laparoscopic
resection was sometimes achieved with 4 trocars, but
g e n e r a l l ya5
th one was required, especially when the
complete mobilization of the splenic flexure was neces-
sitated. Laparoscopic-hand assisted operations were per-
formed as described in our previous paper and were
generally preferred for low rectal tumors treated with a
sphincter-saving procedure [12].
Following aspects were investigated: demographics,
tumor localization, invaded organs and actual pT4 rates,
operative method (type and technique [laparoscopic,
open, conversion] of the procedure, completeness of the
resection [R0, R1 or R2] and the causes for R1-2 resec-
tions, presence or absence of en-bloc resection), inci-
dence of preoperative distant metastasis and synchrone
metastasectomy rates, operation time, intraoperative
bleeding, the perioperative transfusion requirements,
postoperative complications and 30-day mortality, length
of stay, pathological data (type and differentiation of the
tumor, number of harvested lymph nodes, status of sur-
gical margins, presence/absence of vascular and peri-
neural invasion of the tumor, T stage and node status),
follow-up periods and survival.
Complete removal of the tumor without any micro-
scopic (R1) or macroscopic (R2) residue was defined as
R0 resection. If the mass was removed together with
adjacent structures, but not separately, in case of a
tumor adhering to the neighboring organs; the proce-
dure was named as an en-bloc removal. Standard resec-
tion for a colorectal tumor without any additional organ
removal was named as a single organ resection. If the
tumor was adjacent to another organ (locally advanced
or clinical T4 tumor), which necessitated the removal of
multiple organs; the procedure was defined as a multi-
visceral resection. Only if pathological examination
showed an actual invasion of the tumor to the adjacent
organ in case of a multivisceral resection, it was consid-
ered as a pT4 cancer, otherwise the cancer was labeled
as a false-T4 tumor. The perioperative and oncological
data obtained from the patients who underwent multi-
visceral resections due to clinical T4 tumors were com-
pared with those abstracted from single organ resections
in order to find out the short- and long-term conse-
quences of multivisceral resections. In addition, the
demographics and tumor locations were also compared
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possible factors that may play a role in actual pathologi-
cal invasion to the adjacent organs.
Statistical Analysis
Data were analyzed by using SPSS 15.0 for Windows.
Results were given as percentages, mean and standard
deviations or median and ranges. Quantitative and qua-
litative variables were compared with student’st - t e s t
and chi-square test, respectively. The survival rates were
calculated with the Kaplan-Meier test and a log-rank
was used to compare different survival curves. A p value
less than 0.05 was considered significant.
Results
A total of 408 patients (241[59.1%] males with a mean
[± SD] age of 59.1 ± 14.2 years) underwent an elective
procedure for malign or pre-malign colorectal tumors
during the study period in our department. Among
those, 54 (13.2%) cases were excluded since their patho-
logical examinations revealed dysplasia or insitu cancer
w i t h o u ta ni n v a s i o n( n=1 4 ;3 . 4 % ) ,t u m o r so t h e rt h a n
adenocarcinomas (n = 5; 1.2%) or because the operation
was performed for a recurrent disease (n = 35; 8.6%);
leaving 354 patients (59.6 ± 13.8 years old, 210 [59.3%]
males) for the further analyses.
Among the study patients, 90 (25.4%) underwent a
multivisceral resection for a locally advanced (clinical
T4) tumor. An average number of 1.6 ± 0.9 (range: 1 to
4) additional organs were resected in these cases, and
ovaries (n = 24), urinary bladder (n = 23) and small
bowel (n = 19) were the most frequently removed ones.
However, only 31 (34.4%) had real adjacent organ inva-
sions and were classified in pT4 group. This pathologi-
cal analysis revealed that the rate of pT4 tumors was
8.8% among all primary (n = 354) colorectal adenocarci-
nomas. Examinations showed that the absolute patholo-
gical T stages (n = 90) of false-T4 tumors (n = 59) were
pT3 in 48 (53.3%), pT2 in 9 (10.0%) and pT1 in 1
(1.1%) cases; and no residual tumor was found in a
patient’s specimen (1.1%) who received neoadjuvant
chemo-radiation therapy. Demographics were similar
within the patients with pT4 (n = 31, 19 [61.2%]
females, mean [SD] age was 61.0 ± 12.8) and false-T4 (n
= 59, 29 [49.1%] females, mean [SD] age was 56.4 ±
15.6) tumors (p = 0.844 and p = 273 for age and gender,
respectively). When only locally advanced tumors were
considered, rectal cancers (10 out of 47; 21.3%) had a
lower risk for having a real pathological invasion (pT4)
than those located in the colon (21 out of 43; 48.8%) (p
= 0.006). The actual invasion rates were high after pan-
creatic (66.7%), gastric (50%) and uterine (41.2%) resec-
tions and low after the removal of urological organs
(7.1% for ureter and 4.3% for urinary bladder) (Table 1).
Among those who underwent multivisceral resection,
en-bloc removals were achieved in 84 (93.3%). However,
the adjacent organs were resected separately in 6 cases,
due to the technical reasons, in whom the tumors had
invaded ovary (n = 3), small bowel (n = 2) or ureter (n
= 1). In addition, in 2 (2.2%) cases, who had bulky colo-
nic and rectal cancers in multiviseral resection group,
en bloc duodenum and urinary bladder removals were
completed and R0 resections were intraoperatively
anticipated, however the pathological examinations
revealed positive surgical margins (R1 resection). Thus,
an en-bloc R0 resection was achieved in 82 (91.1%)
patients who underwent multivisceral resections for col-
orectal cancer.
The demographic information and the localization of
the tumor were evaluated in order to find out possible
factors that may play a role in actual pathological inva-
sion to the adjacent organs. Although there were more
m e n( n=2 1 0 ;5 9 . 3 % )t h a nw o m e n( n=1 4 4 ;4 0 . 7 % )
operated for colorectal cancer, males (42 out of 210;
20%) had lower risk to have a clinical T4 tumor than
females (48 out of 144; 33.3%) (p < 0.05). The distribu-
tion of single organ and multivisceral resections were
identical among the tumors located in the colon and
rectum (p > 0.05).
The perioperative data concerning single organ and
multivisceral resections were compared. The rate of
neoadjuvant chemoradiation therapy was similar within
t h es i n g l eo r g a nr e s e c t i o n( n=1 0 6 ,7 1 . 6 % )a n dm u l t i -
visceral resection (n = 34, 72.3%) groups (p = 0.924).
The reasons for the omission of neaoadjuvant
Table 1 The Additionally Resected Organs: The Rate of
Resection as a Part of Multivisceral Resection and The
Possibility of an Actual Invasion
Organs Clinical-T4 (%) Actual Invasion (%)
Ovary 24 (26.6) 7/24 (29.2)
Urinary bladder 23 (25.5) 1/23 (4.3)
Bowel 19 (21.1) 7/19 (36.8)
Uterus 17 (18.9) 7/17 (41.2)
Ureter 14 (15.5) 1/14 (7.1)
Vagina 13 (14.4) 3/13 (23.1)
Abdominal wall 12 (13.3) 3/12 (25.0)
Appandix vermiformis 7 (7.7) 2/7 (28.6)
Duodenum 6 (6.7) 2/6 (33.3)
Stomach 4 (4.4) 2/4 (50.0)
Pancreas 3 (3.3) 2/3 (66.7)
Prostate 3 (3.3) 1/3 (33.3)
Spleen 2 (2.2) 0/2 (0)
Colon 1 (1.1) 0/1 (0)
Coccyx 1 (1.1) 0/1 (0)
Gall bladder 1 (1.1) 0/1 (0)
Total 90 (100) 31/90 (34.4)
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tion at the upper rectum (n = 10), preoperative under-
staging (n = 2) and surgeon preference in a case with
synchronous resectable hepatic metastasis. Laparoscopy
was seldom initiated and the risk of conversion was
higher in patients with clinical-T4 tumors (p < 0.05 for
both comparisons). The rates of extended procedures
(extended right/left hemicolectomy or subtotal resec-
tion or total proctocolectomy) for colon cancer, were
also identical in patients who underwent single organ
(31 [19.5%] out of 116) and multivisceral (15 [34.9%]
out of 43) resections (p = 0.468). Similarly, the possibi-
lity of a sphincter-saving procedures (low anterior/
intersphincteric resections/total proctocolectomy with
stapled or hand-sewn coloanal or ileo-anal anastomo-
sis) in single organ resection (101 [68.2%] out of 148)
and multiorgan resection (29 [61.7%] out of 47) groups
were alike in patients with rectal cancer (p = 0.407).
Among those who had low anterior resections, the
rates of intersphincteric resections were identical in
single organ (27 [26.7%] out of 101) and multivisceral
(9 [31.0%] out of 29) resection groups (p = 0.951).
Intra- and post-operative data including length of hos-
pital stay, and complications were similar within the
groups, except operation time, amount of bleeding and
transfusion requirement, which were significantly
higher in cases that underwent multivisceral resections
(p < 0.05 for all comparisons). 30-day mortality was
observed in 4.2% of all patients (n = 15), and the
causes for death were pulmonary embolism (n = 5),
cardiac insufficiency or poor general condition (n = 5),
intra-abdominal sepsis (n = 3) and pulmonary infec-
tion/pneumonia (n = 2) (Table 2).
The oncological results revealed almost no significant
difference within the groups for the most of the com-
parisons. As expected, the number of pT4 tumors was
higher in multivisceral resection group (p < 0.01). But,
after the exclusion of pT4 tumors, the distribution of
different T stages among the groups was not statistically
significant (p = 0.392). In addition, the amount of har-
vested lymph nodes and the rate of perineural invasion
were less in single organ resection group (p < 0.05 for
both comparisons) (Table 2).
A total of 45 (12.7%) patients (34 [12.9%] in single
organ and 11 [12.2%] in multivisceral resection group)
were lost in contact during the follow-up period. After
mean follow-up periods of 22 (range 0 to 124) and 25
(range 0 to 76) months (p = 0.986), the 5-year survival
rates were 64.6% and 69.4% for single organ and multi-
visceral resection groups, respectively; and Kaplan-Meier
tests denied to reveal a significant difference in sub-
group analyses regarding node negative, node positive
and metastatic groups of patients (Figure 1).
Discussion
Colorectal cancer is one of the most common malignan-
cies observed, and the treatment generally includes a
surgical intervention. However, the operation may some-
times be challenging if the tumor locally invades other
intraabdominal organs which is the case in 5 to 20% of
the patients. An en-bloc resection of the tumor with
adjacent organs has been advocated in order to achieve
an adequate surgical treatment in these cases. In many
studies, the risk and outcome after multivisceral resec-
tions for locally advanced tumors have been discussed
and mostly it is believed that an en-bloc resection of the
mass with the adjacent struct u r e si st h eb e s ts u r g i c a l
option for the treatment of clinical T4 cancers
[3,9,10,13,14]. However data remains conflicting, since
some other series revealed that multivisceral resections
may be associated with a higher morbidity rate [15,16].
In addition, early postoperative mortality up to 12% has
been reported [11]. Accordingly, a recent observational
national study on the SEER Registry has declared that
only 33.3% of the 8380 patients with locally advanced
colorectal cancer were managed with multivisceral
resection, and stated the necessity of further research on
this particular subject [17,18]. Thus, current study aims
to evaluate the outcomes after multivisceral resections
and particularly evaluate the safety of this challenging
procedure and long term results.
We have analyzed a total of 354 patients operated for
primary colorectal cancers in our institution within a
period of almost 10 years, and among those, 90 (25.4%)
required a multivisceral resection due to a locally
advanced disease. Ovaries, urinary bladder and small
bowel were the most frequently resected additional
organs. The rate of abdominal wall resection is less than
those presented in the previous data, probably because
we did not consider and document in operation notes
simple peritoneal resections as ‘tumor invasion to the
abdominal wall’ unless muscular structure was pene-
trated by the tumor [3,10]. This is probably one of the
reasons of low pT4 tumor rate in our study, since it has
been demonstrated in previous studies that adhesions
between tumor and other organs harbor malignant cells
approximately 40% of cases, and sometimes increases up
to 72.5% [3,7,9,10,16]. In the current series, pathological
analysis has revealed that only one third of all clinically
T4 tumors were actual pT4 cancers. Although current
study does not evaluate the preoperative prediction for
T4 cancers, it may be concluded that most of the clini-
cal T4 tumors are recognized at the time of surgery, as
has mentioned in previous studies [10,16]. In addition,
pathological analyses denied a pT4 cancer after most of
urological organ resections including ureter or urinary
bladder, however in our opinion, these results do not
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and Pathological Features in Patients Who Underwent Single Organ and Multivisceral Resections
Single organ resections (n = 264) Multivisceral resections (n = 90) p
Demographics
Age 59.7 ± 13.7 59.4 ± 13.9 0.871
Gender (males) 168 (63.3) 42 (46.7) 0.005
Localization (Colon/Rectum) 116 (48.5)/148 (51.5) 43 (56.7)/47 (43.3) 0.527
Preoperative metastasis 32 (12.1) 11 (12.2) 0.980
Synchrone metastasectomy 10 (3.8) 4 (4.4) 0.759
Operation technique
Conventional/laparoscopic 110 (41.7)/154 (58.3) 54 (60.0)/36 (40.0) 0.003
Conversion (%) 25/154 (16.2) 15/36 (41.7) 0.001
Intra- and Postoperative Parameters
Operation time (min) (n = 252) 203.0 ± 53.4 (n = 83) 256.4 ± 77.0 0.0001
Intraoperative bleeding (ml) (n = 213) 250 0[1-4000] (n = 68) 450 [100-2700] 0.0001
Total transfusion
Rate 119/256 (47.4) 61/88 (68.5) 0.0001
Amount 0 (0-12) 2 (0-26) 0.001
Synchrone metastasectomy 10 (3.8) 4 (4.4) 0.759
Length of hospital stay 8.6 ± 6.8 9.0 ± 4.9 0.652
Complications (n = 264) (n = 90)
Surgical site infection 13 (4.9) 6/90 (6.6) 0.590
Wound infection 6 (2.3) 3 (3.3)
Evisceration 5 (1.9) 2 (2.2)
Intraabdominal abscess 2 (0.8) 1 (1.1)
Fistula 16 (6.0) 5 (5.5) 0.831
Anastomotic 14 (5.3) 2 (2.2)
Urinary 1 (0.4) 2 (2.2)
Biliary 1 (0.4) 1 (1.1)
Anastomotic leakage 14 (5.3) 2 (2.2) 0.378
Ileus 11 (4.2) 5 (5.5) 0.568
Nonsurgical 5 (1.9) 3 (3.3) 0.429
Intrabdominal hemorrhage 7 (2.7) 4 (4.4) 0.483
Urinary retantion/leakage 2 (0.8) 1 (1.1) 0.999
Missed bowel injury 1 (0.4) 1 (1.1) 0.449
Reoperation 5 (2.0) 2 (1.1) 0.999
Intrabdominal hemorrhage 2 (0.8) 1 (1.1)
Anastomotic leakage 2 (0.8) 0 (0)
Missed bowel injury 1 (0.4) 1 (1.1)
Overall 55 (20.9) 22 (24.4) 0.516
30-day mortality 11 (4.2) 4 (4.4) 0.999
T Stage 0.0001
pT0*/pT1/pT2/pT3/pT4 16 (6.1)/12 (4.5)/37 (14)/199 (75.4)/0 1 (1.1)/1 (1.1)/9 (10)/48 (53.3)/31 (34.4)
Harvested lymph nodes 13.7 ± 7.3 16.0 ± 9.6 0.043
N Stage 0.227
pN (negative)/(positive) 148 (56.1)/116 (43.9) 54 (60)/44 (40)
Vascular invasion 103 (39.0) 43 (47.7) 0.363
Perineural invasion 116 (43.9) 54 (60.0) 0.043
Differentiation 0.227
Poorly/Moderately/Well/Undetermined or missed 28 (10.6)/208 (78.8)/12 (4.5)/16 (6.1) 8 (8.9)/77 (85.6)/4 (4.4)/1 (1.1)
Positive surgical margin (R1-R2 resection) 2 (0.8) 2 (2.2) 0.268
* includes only pT0 rectal tumors after neoadjuvant chemo-radiation therapy (complete response)
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T4 cancer invading urological organs since it is unpre-
dictable whether or not an actual invasion exists.
The rates of clinical T4 tumors and R0 resections
seem to be higher than previously published data
[10,15-17]. The higher risk of confronting a T4 tumor
in the current data may be speculated to be related to
two factors: First, the early detection of colorectal
tumors is rare in our district and most of the patients
(93.2%) presented with pT3 or pT4 cancers as reported
in our previous paper [19]. Secondly, since our unit
takes part in a level 3 center, patients with more
advanced tumors might be referred to our institution.
Some may also question the indication for multivisceral
resection in our series, particularly for those located in
the rectum, since the actual invasion rate in urinary
bladder was only 4.3% and the prostate resections were
necessitated in only 3 cases, which might be lower than
had expected. We do not know whether these findings
were related to our strategy neoadjuvant chemoradiation
application in all distally located advanced rectal can-
cers, or to the patient selection, which was performed
by a multidisciplinary council that rule out to operate
the patients who had a potential risk for R1-2 resections.
In our opinion, this highly conservative strategy lead
that a R0 and en-bloc removal was achieved in most
(91.1%) of the patients who underwent a multivisceral
resection.
Current study has investigated the patient and proce-
dure related information of single organ and multivisc-
eral resections. It was observed that females had a
higher risk to undergo a multivisceral resection due to a
clinical T4 tumor than males, and colon tumors carried
a greater risk of a pathological invasion (pT4). This
demographic difference was previously mentioned by
others, but has not been statistically confirmed in a sin-
gle institution study [10,20,21]. The data analyzing SEER
Registry have also verified this finding and have con-
cluded that females are under a higher risk for a multi-
visceral resection in both colon (odds ratio 1.45; range
1.29-1.63) and rectal (odds ratio 4.07; range 3.13-5.29)
cancers [17]. It is hard to speculate why women with
colorectal cancers are under a higher risk for clinical T4
and consequent multivisceral resections, but it may be
related to the anatomic location of uterus and ovaria in
women. It has been speculated that the female internal
genitalia may cause a barrier effect against tumor inva-
sion keeping urinary bladder safe which is a common
location for tumor invasion in most series and it is diffi-
cult to remove. This anatomic construction in women
may lead a higher en-bloc resection rate of genital
organs that can be easily resected with the adjacent
structures [5].
Current data revealed that more extensive lymphatic
resections are performed and thus the number of har-
vested lymph nodes is increasing in cases, who
Figure 1 Kaplan-Meier analyses revealed no statistical difference in overall survival between the groups when the comparisons
included node negative (p = 0.374) (A), node positive (p = 0.765) (B) and metastatic (p = 0.788) (C) cases; as well as all patients (p =
0.397) (D).
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current study has shown the number of extended colo-
nic resections is elevated but not significantly higher
than single organ resections, and the possibility of hav-
ing a sphincter saving procedure has not changed.
Furthermore, operation time, intraoperative bleeding,
and the rate and amount of perioperative transfusions
were significantly higher in patients who underwent a
multivisceral resection, which was also the case in pre-
vious studies and was speculated to be related to the
extent of the surgery [10,15,16]. The introduction of
laparoscopy and the possibility of procedure completion
without a conversion were also significantly less in
patients with clinical T4 tumors. Besides, a laparoscopic
multivisceral resection was achieved in 21 patients,
which may demonstrate that laparoscopy may be used
in selected clinical T4 colorectal cancers. In our opinion,
locally advanced colorectal cancers and consequent mul-
tivisceral resections are challenging procedures that may
alter surgeons’ routine practice to a more aggressive
procedure that may cause some adverse outcomes
including an extended operation time, increased bleed-
ing and transfusion rate and limitation in initiation and
completion of laparoscopic technique; but they do not
increase the possibility of abdominoperineal resections
in case of rectal cancers.
There has been a disagreement in the literature on
whether or not a multivisceral resection is associated
with a higher complication rate. Most of the studies
reported reasonable complication rates comparable to
single organ resections [3,15,22,23]. Besides, others sta-
ted higher risks of morbidity up to 33 and 50% [10,24].
A comparative study evaluating short-term and long-
term results after standard operations and multivisceral
resections for colorectal cancer exposed the overall
complication rates as 17.8% and 49.1% after these proce-
dures, respectively (p < 0.0001). In this series, it was
mentioned that higher morbidity rate might be related
to the increased number of anastomosis and the
extended resections [16]. Although some comparative
studies denied an increase risk in postoperative mortal-
ity compared to single organ removals, others reported
unacceptably high rates in patients underwent multivisc-
eral resections [3,10,11,16,22,25,26]. Current study has
revealed that patients who underwent multivisceral
resections due to locally advanced tumors are not under
a higher risk than those managed with single organ
removals regarding the rates of postoperative complica-
tions (20.9% vs 24.4%) or 30-day mortality (4.2% vs
4.4%). Although some have reported excellent surgical
complication risks as low as 1.4%, ours may be consid-
ered to be lower than expected [3]. It is probably
because we had evaluated all patients in a multidisci-
plinary council prior to the operations, or may be
related to the fact that the rate of multivisceral resec-
tions was more in patients with tumors located at the
colon, which are obviously under a lower risk for com-
plications compared to rectal cancers. In previous ana-
lyses, mortality rates between 0 to 12% were reported in
patients underwent multivisceral resections [9-11,16].
We believe that the mortality rate in the multiple organ
resection group in our study was acceptable and com-
parable to previously published data [9-11,16]. In con-
trast, the mortality rate in single organ resection group
in our study seems to be higher than those reported in
the literature, although some others have stated higher
incidences as ours [14,26,27]. For example, in a
national-based study in a French population, Mitry et al
has reported a mortality risko f6 . 2 %i np a t i e n t su n d e r -
went a resection for cure [26]. Thus, in our opinion our
data support that multivisceral resections can be per-
formed with acceptable postoperative morbidity and
mortality rates in patients with clinical T4 colorectal
cancers as mentioned in previous studies [10,14].
The oncological outcome after multivisceral resection
has the paramount significance. Previous data pre-
sented discouraging 5-year survival rates as low as 30
to 38% after multivisceral resections even in cases in
whom R0 resection was achieved [10,22]. More recent
studies have mentioned reasonable 5-year survival
rates up to 76% in patients with negative lymph nodes
after this procedure, but the results were not compared
with those obtained from single organ resections
[3,10,11]. In addition, it has been also shown that pT3
and pT4 tumors may have similar oncological results
[15,16]. However, in our opinion, a comparison of
oncological outcomes obtained from pT3 and pT4
tumors may include some bias and can not rationalize
the necessity of multivisceralr e s e c t i o n s ,s i n c et h ef i n a l
pathological examinations of clinical T4 tumors may
present pT2 or pT1 cancers as observed in the current
study (n = 9 [10%] for pT2 and n = 1 [1.1%] for pT1).
Thus, it may be logical to compare the results of mul-
tivisceral and single organ resections in order to find
out the realistic benefit in oncological perspective after
this challenging procedure. Montesani et al gave their
experience on 525 patients comparing the outcomes
after single organ or multivisceral resections, and
showed no difference in long-term results between the
groups; however the 5-year survival rates were as lim-
ited as 30% in this series [22]. In addition to the find-
ing revealing similar long term oncological results in
single organ and multiple organ resection groups in
the current study, subgroup analyses also have shown
identical 5-year survival rates when only node negative,
node positive and metastatic patients were considered.
In our opinion, these consequences confirm that multi-
visceral resections may be warranted for all clinical T4
Gezen et al. World Journal of Surgical Oncology 2012, 10:39
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term oncological benefit.
Current study may have some limitations predomi-
nantly causing from the retrospective design of the data
abstraction and the missed information particularly
belong to those operated during the initial phase of the
study period. In addition, some data may interfere with
other results, such as intraoperative bleeding and perio-
perative transfusion rates may be originated from the
limited number of laparoscopic procedures in multivisc-
eral resections, since previous multicenter randomized
studies have shown that open technique may increase
the amount of intraoperative bleeding and the require-
ment of transfusion [27]. However, in our opinion,
besides these limitations, current data still support the
principle that an en-bloc multivisceral resection should
be decided in case of a clinical T4 tumor, since it may
offer a reasonable survival rate with an acceptable
increased risk in perioperative outcomes.
Conclusion
In conclusion, clinical T4 tumors are not rare, and may
be more frequently observed in females. Ovary, urinary
bladder and bowel are the most commonly affected
organs. An en-bloc, R0, multivisceral resection may be
achieved in most of the cases. A true invasion (pT4)
may be observed approximately in one third of all clini-
cal T4 tumors and is more common among colon can-
cers. The rate of sphincter-saving procedures was
identical within both techniques, but laparoscopic pro-
cedures are less commonly aimed and completed in
cases that required a multivisceral resection. When
compared with single organ resections, this technique
does not increase morbidity but operation time, intrao-
perative bleeding and perioperative transfusion rate and
amount. Survival rates after single organ and multivisc-
eral resections are identical.
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